The results were consistent with the preliminary results Eli Lilly shared in January, which disappointed investors.

A new study examines how cost, side effects, and other factors influence whether people stop GLP-1s, while Noom cuts staff to ...

When Jeanne began to seriously consider taking Zepbound, one of the new-generation weight-loss drugs ... who was attending boot camp five days a week, was at her thinnest — 160 pounds.